MarketPeel
Insider Trading Intelligence
KF

Karen Firestone

AMLX
DIRECTOR · AMYLYX PHARMACEUTICALS, INC. · CIK 0001969821
FILING MIX · LIFETIME100%/0%
BUYS
10
SELLS
0
TOTAL VALUE
$350.6K
COMPANIES
1
ACTIVE SINCE
Mar 2023
HOLDINGS NOW
24,372
AVG SELL PX
TRADE KIND
SHOWING 10 / 10
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Karen Firestone, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+50.00%+0.77%+0.54%+0.23%-0.70%
14d4+50.00%+3.29%+2.01%+1.29%-2.97%
30d4+75.00%+19.54%+2.70%+16.83%+20.55%
60d4+75.00%+41.44%+3.54%+37.90%+6.73%
90d4+50.00%+12.22%+6.67%+5.55%-9.28%
180d4+50.00%-14.86%+10.83%-25.69%-15.13%
1y4(1 pending)+33.33%+67.56%+26.63%+40.93%-101.00%
2y4(2 pending)+0.00%-50.22%+46.72%-96.94%-96.94%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AMLX · 24,372 shares · as of Jun 4, 2026
016,72533,45050,17566,900202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 10 buys / 0 sellsCOVERAGE · 14 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
24,37224,372Jun 4, 2026Jun 8, 2026View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASE
3,800$13.51$51.3K66,900May 21, 2026May 26, 2026View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASE
8,100$12.45$100.8K63,100Dec 23, 2025Dec 23, 2025View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jun 5, 2025Jun 9, 2025View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASE
50,000$2.13$106.6K55,000Sep 5, 2024Sep 9, 2024View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jun 6, 2024Jun 7, 2024View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASE
4,000$14.97$59.9K5,000Dec 15, 2023Dec 19, 2023View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,9083,908Jun 8, 2023Jun 12, 2023View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
27,40327,403Mar 16, 2023Mar 20, 2023View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASE
1,000$31.99$32.0K1,000Mar 16, 2023Mar 20, 2023View →
Other insiders · AMLX
Loading peer insiders…
About this filer
CIK 0001969821
ROLE
Director
PRIMARY
AMLX
COMPANIES
1
ACTIVE SINCE
Mar 2023
MARKETPEEL · /INSIDER/0001969821DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback